Vigil Neuroscience, Inc.
VIGL
$7.95
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.40% | -7.47% | 6.04% | -5.22% | -0.73% |
| Total Depreciation and Amortization | 9.73% | 0.00% | 3.64% | 1.80% | 73.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.61% | -16.27% | 30.06% | 35.78% | 23.40% |
| Change in Net Operating Assets | -2.31% | -13.60% | 1,839.44% | 8.26% | -0.49% |
| Cash from Operations | -9.20% | -16.96% | 124.84% | -0.97% | 1.37% |
| Capital Expenditure | -- | 100.00% | 100.00% | 95.90% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 42.79% | -26.62% | -207.92% | 104.77% | 124.03% |
| Cash from Investing | 41.06% | -26.53% | -208.25% | 104.72% | 123.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 155.92% | 8,269.81% | -7.27% | -98.47% | 2,322.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 155.92% | 8,269.81% | 37,373.58% | -98.45% | 2,453.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,554.98% | -22.39% | 489.52% | 60.82% | 99.75% |